|
1
|
Hasan TF, Hasan H and Kelley RE: Overview
of acute ischemic stroke evaluation and management. Biomedicines.
9(1486)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Pan J, Konstas AA, Bateman B, Ortolano GA
and Pile-Spellman J: Reperfusion injury following cerebral
ischemia: Pathophysiology, MR imaging, and potential therapies.
Neuroradiology. 49:93–102. 2007.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Trendelenburg G: Molecular regulation of
cell fate in cerebral ischemia: Role of the inflammasome and
connected pathways. J Cereb Blood Flow Metab. 34:1857–1867.
2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Orellana-Urzúa S, Rojas I, Libano L and
Rodrigo R: Pathophysiology of ischemic stroke: Role of oxidative
stress. Curr Pharm Des. 26:4246–4260. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Domínguez C, Delgado P, Vilches A,
Martín-Gallán P, Ribó M, Santamarina E, Molina C, Corbeto N,
Rodríguez-Sureda V, Rosell A, et al: Oxidative stress after
thrombolysis-induced reperfusion in human stroke. Stroke.
41:653–660. 2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhou T, Prather ER, Garrison DE and Zuo L:
Interplay between ROS and antioxidants during ischemia-reperfusion
injuries in cardiac and skeletal muscle. Int J Mol Sci.
19(417)2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Li P, Stetler RA, Leak RK, Shi Y, Li Y, Yu
W, Bennett MVL and Chen J: Oxidative stress and DNA damage after
cerebral ischemia: Potential therapeutic targets to repair the
genome and improve stroke recovery. Neuropharmacology. 134:208–217.
2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yang Q, Huang Q, Hu Z and Tang X:
Potential Neuroprotective treatment of stroke: Targeting
excitotoxicity, oxidative stress, and inflammation. Front Neurosci.
13(1036)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li W and Yang S: Targeting oxidative
stress for the treatment of ischemic stroke: Upstream and
downstream therapeutic strategies. Brain Circ. 2:153–163.
2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Shirley R, Ord EN and Work LM: Oxidative
stress and the use of antioxidants in stroke. Antioxidants (Basel).
3:472–501. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Olie RA, Hall J, Natt F, Stahel RA and
Zangemeister-Wittke U: Analysis of ribosyl-modified, mixed backbone
analogs of a bcl-2/bcl-xL antisense oligonucleotide. Biochim
Biophys Acta. 1576:101–109. 2002.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Dimitrijevic OB, Stamatovic SM, Keep RF
and Andjelkovic AV: Absence of the chemokine receptor CCR2 protects
against cerebral ischemia/reperfusion injury in mice. Stroke.
38:1345–1353. 2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sun R, Peng M, Xu P, Huang F, Xie Y, Li J,
Hong Y, Guo H, Liu Q and Zhu W: Low-density lipoprotein receptor
(LDLR) regulates NLRP3-mediated neuronal pyroptosis following
cerebral ischemia/reperfusion injury. J Neuroinflammation.
17(330)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Liu HB, Li QY, Zhang XD, Shi Y and Li JY:
The neuroprotective effects of galectin-1 on Parkinson's disease
via regulation of Nrf2 expression. Eur Rev Med Pharmacol Sci.
26:623–636. 2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Vallecillo-Zúniga ML, Rathgeber MF,
Poulson PD, Hayes S, Luddington JS, Gill HN, Teynor M, Kartchner
BC, Valdoz J, Stowell C, et al: Treatment with galectin-1 improves
myogenic potential and membrane repair in dysferlin-deficient
models. PLoS One. 15(e0238441)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cheng YH, Jiang YF, Qin C, Shang K, Yuan
Y, Wei XJ, Xu Z, Luo X, Wang W and Qu WS: Galectin-1 contributes to
vascular remodeling and blood flow recovery after cerebral ischemia
in mice. Transl Stroke Res. 13:160–170. 2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Arda-Pirincci P and Aykol-Celik G:
Galectin-1 reduces the severity of dextran sulfate sodium
(DSS)-induced ulcerative colitis by suppressing inflammatory and
oxidative stress response. Bosn J Basic Med Sci. 20:319–328.
2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Carlos CP, Silva AA, Gil CD and Oliani SM:
Pharmacological treatment with galectin-1 protects against renal
ischaemia-reperfusion injury. Sci Rep. 8(9568)2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ye Y, Wang W, Zhang W, Peng Y, Liu Y, Yu
S, Chen Q, Geng L, Zhou L, Xie H, et al: Galectin-1 attenuates
hepatic ischemia reperfusion injury in mice. Int Immunopharmacol.
77(105997)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Xia Q, Li X, Zhou H, Zheng L and Shi J:
S100A11 protects against neuronal cell apoptosis induced by
cerebral ischemia via inhibiting the nuclear translocation of
annexin A1. Cell Death Dis. 9(657)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chen C, Ma Q, Jiang J, Wang T, Qiu L and
Liu A: Protective effects of nuciferine in middle cerebral artery
occlusion rats based on transcriptomics. Brain Sci.
12(572)2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang J, Lin X, Mu Z, Shen F, Zhang L, Xie
Q, Tang Y, Wang Y, Zhang Z and Yang GY: Rapamycin Increases
collateral circulation in rodent brain after focal ischemia as
detected by multiple modality dynamic imaging. Theranostics.
9:4923–4934. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Tian W, Zhu M, Zhou Y, Mao C, Zou R, Cui
Y, Li S, Zhu J and Hu C: Electroacupuncture pretreatment alleviates
cerebral ischemia-reperfusion injury by regulating mitophagy via
mTOR-ULK1/FUNDC1 axis in rats. J Stroke Cerebrovasc Dis.
31(106202)2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wang C, Ma Z, Wang Z, Ming S, Ding Y, Zhou
S and Qian H: Eriodictyol attenuates MCAO-induced brain injury and
neurological deficits via reversing the autophagy dysfunction.
Front Syst Neurosci. 15(655125)2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Otsuka S, Itashiki Y, Tani A, Matsuoka T,
Takada S, Matsuzaki R, Nakanishi K, Norimatsu K, Tachibe Y,
Kitazato R, et al: Effects of different remote ischemia
perconditioning methods on cerebral infarct volume and neurological
impairment in rats. Sci Rep. 13(2158)2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Paris L, Roussel M, Pereira B, Delbac F
and Diogon M: Disruption of oxidative balance in the gut of the
western honeybee Apis mellifera exposed to the intracellular
parasite Nosema ceranae and to the insecticide fipronil. Microb
Biotechnol. 10:1702–1717. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bhattacharyya A, Chattopadhyay R, Mitra S
and Crowe SE: Oxidative stress: An essential factor in the
pathogenesis of gastrointestinal mucosal diseases. Physiol Rev.
94:329–354. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Nishi T, Maier CM, Hayashi T, Saito A and
Chan PH: Superoxide dismutase 1 overexpression reduces MCP-1 and
MIP-1 alpha expression after transient focal cerebral ischemia. J
Cereb Blood Flow Metab. 25:1312–1324. 2005.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bowler RP, Sheng H, Enghild JJ, Pearlstein
RD, Warner DS and Crapo JD: A catalytic antioxidant (AEOL 10150)
attenuates expression of inflammatory genes in stroke. Free Radic
Biol Med. 33:1141–1152. 2002.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Taylor JM, Crack PJ, Gould JA, Ali U,
Hertzog PJ and Iannello RC: Akt phosphorylation and NFkappaB
activation are counterregulated under conditions of oxidative
stress. Exp Cell Res. 300:463–475. 2004.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ochoa CD, Wu RF and Terada LS: ROS
signaling and ER stress in cardiovascular disease. Mol Aspects Med.
63:18–29. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zhao SC, Ma LS, Chu ZH, Xu H, Wu WQ and
Liu F: Regulation of microglial activation in stroke. Acta
Pharmacol Sin. 38:445–458. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Wong CHY and Crack PJ: Modulation of
neuro-inflammation and vascular response by oxidative stress
following cerebral ischemia-reperfusion injury. Curr Med Chem.
15:1–14. 2008.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Fisher M: Injuries to the vascular
endothelium: Vascular wall and endothelial dysfunction. Rev Neurol
Dis. 5 (Suppl 1):S4–S11. 2008.PubMed/NCBI
|
|
35
|
Kataoka H, Kim SW and Plesnila N:
Leukocyte-endothelium interactions during permanent focal cerebral
ischemia in mice. J Cereb Blood Flow Metab. 24:668–676.
2004.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Hsieh YW, Lin KC, Korivi M, Lee TH, Wu CY
and Wu KY: The reliability and predictive ability of a biomarker of
oxidative DNA damage on functional outcomes after stroke
rehabilitation. Int J Mol Sci. 15:6504–6516. 2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liu FT and Rabinovich GA: Galectins:
Regulators of acute and chronic inflammation. Ann NY Acad Sci.
1183:158–182. 2010.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Rodrigues LC, Kabeya LM, Azzolini AECS,
Cerri DG, Stowell SR, Cummings RD, Lucisano-Valim YM and
Dias-Baruffi M: Galectin-1 modulation of neutrophil reactive oxygen
species production depends on the cell activation state. Mol
Immunol. 116:80–89. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Arda-Pirincci P, Sacan O, Ozal-Coskun C,
Aykol-Celik G, Karabulut-Bulan O, Yanardag R and Bolkent S:
Galectin-1 exhibits a protective effect against hepatotoxicity
induced by dextran sulfate sodium in mice. Hum Exp Toxicol.
39:423–432. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Ou D, Ni D, Li R, Jiang X, Chen X and Li
H: Galectin-1 alleviates myocardial ischemia-reperfusion injury by
reducing the inflammation and apoptosis of cardiomyocytes. Exp Ther
Med. 23(143)2022.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Huang XT, Liu W, Zhou Y, Sun M, Yang HH,
Zhang CY and Tang SY: Galectin-1 ameliorates
lipopolysaccharide-induced acute lung injury via AMPK-Nrf2 pathway
in mice. Free Radic Biol Med. 146:222–233. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Li Y, Chen N, Wu C, Lu Y, Gao G, Duan C,
Yang H and Lu L: Galectin-1 attenuates neurodegeneration in
Parkinson's disease model by modulating microglial MAPK/IκB/NFκB
axis through its carbohydrate-recognition domain. Brain Behav
Immun. 83:214–225. 2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Aalinkeel R, Mangum CS, Abou-Jaoude E,
Reynolds JL, Liu M, Sundquist K, Parikh NU, Chaves LD, Mammen MJ,
Schwartz SA and Mahajan SD: Galectin-1 reduces neuroinflammation
via modulation of nitric oxide-arginase signaling in HIV-1
transfected microglia: A gold nanoparticle-galectin-1 ‘nanoplex’ a
possible neurotherapeutic? J Neuroimmune Pharmacol. 12:133–151.
2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Castillo-González R, Cibrian D,
Fernandez-Gallego N, Ramírez-Huesca M, Saiz ML, Navarro MN, Fresno
M, de la Fuente H and Sánchez-Madrid F: Galectin-1 expression in
CD8+ T lymphocytes controls inflammation in contact
hypersensitivity. J Invest Dermatol. 141:1522–1532.e3.
2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Starossom SC, Mascanfroni ID, Imitola J,
Cao L, Raddassi K, Hernandez SF, Bassil R, Croci DO, Cerliani JP,
Delacour D, et al: Galectin-1 deactivates classically activated
microglia and protects from inflammation-induced neurodegeneration.
Immunity. 37:249–263. 2012.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Li X, Shi W, Wei G, Lv J, Wang D, Xing B,
Zhou J, Zhao J and Sun H: Galectin-1 promotes angiogenesis and
chondrogenesis during antler regeneration. Cell Mol Biol Lett.
28(40)2023.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Ishibashi S, Kuroiwa T, Sakaguchi M, Sun
L, Kadoya T, Okano H and Mizusawa H: Galectin-1 regulates
neurogenesis in the subventricular zone and promotes functional
recovery after stroke. Exp Neurol. 207:302–313. 2007.PubMed/NCBI View Article : Google Scholar
|
